Trial · NCT07897695
Effects of Strain Counterstrain Versus Post Isometric Relaxation on Pain, Headache Frequency, and Quality of Life in Females With Cervicogenic Headache.
NCT07897695, Not applicable, Completed, Qurat Ul Ain Ashfaq
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Strain Counterstrain Versus Post Isometric Relaxation on Pain, Headache Frequency, and Quality of Life in Females With Cervicogenic Headache. Trials, record NCT07897695. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07897695
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Strain Counterstrain Versus Post Isometric Relaxation on Pain, Headache Frequency, and Quality of Life in Females With Cervicogenic Headache.
- NCT number
- NCT07897695
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 34 participants, actual
- Lead sponsor
- Qurat Ul Ain Ashfaq
- Conditions
- Cervicogenic Headache
- Interventions
- Post Isometric Relaxation, Strain Counterstrain
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain Measured by Numeric Pain Rating Scale | AT Baseline to 6 weeks | It's an unidimensional pain scale, a self-reported measurement with an 11-point number rating that ranges from no pain (0) to the worst pain (10). Interpreted as mild (1-3), moderate (4-6), or severe (7-10). |
| Primary | Headache episode measured by the Headache Frequency Diary | AT Baseline to 6 weeks | Headache episodes will be recorded using the Headache Frequency Diary each week, which includes the number, duration, characteristics, triggers, and functional impact of headache attacks. Headache frequency was classified into 4 groups: 0-1, 2-3, 4-5, and 6-7 episodes per week |
| Secondary | Headache-Related Quality of Life and Functional Impact | AT Baseline to 6 weeks | The overall effect of headache on participant's functioning and quality of life was measured using the Headache Impact Test (HIT-6™). The six items are answered on a scale ranging from never (6) to always (13) with five answer options for each item. The total score is from 36 points to 78 points, with higher scores representing a higher impact on headaches in daily life. A score of ≤49 indicates little or no impact, 50-55 indicates some impact, 56-59 indicates substantial impact, and 60-78 indicates severe impact. The HIT-6 has shown good psychometric properties, including high internal consistency (Cronbach's α = 0.89-0.90) and good test-retest reliability (ICC = 0.78-0.80) over 14 days. It has been validated by its correlation with known QOL instruments such as the SF-8, SF-36, and MIDAS. The instrument was 93.1% sensitive and 79.4% specific at a cut-off point of ≥56, with an overall classification accuracy of 88.7% for migraine impact. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07897695
GET https://conductscience.org/api/trials/v1/NCT07897695/registered